Testosterone gel should be promptly discontinued until thecause of virilization has been identified. Changes in insulin sensitivity or glycemic control mayoccur in patients treated with androgens. Because the reactionsare reported voluntarily from a population of uncertain size, it is not alwayspossible to reliably estimate their frequency or establish a causalrelationship to drug exposure. The patient should avoid swimming or showering or washingthe administration site for a minimum of 2 hours after application seeCLINICAL PHARMACOLOGY. In order to prevent transfer to another person, clothingshould be worn to cover the application sites. Hands should be washed thoroughly with soap and waterafter Vogelxo has been applied. Table 2 has specific dosing guidelines for whenthe metered pump is used. No specific interactions with imaging contrast agents are known, but testosterone therapy can influence certain lab tests (such as PSA, hematocrit, and lipid levels), so clinicians interpreting results should know a patient is using it. Early signs and symptoms of puberty have occurred in young childrenwho have come in direct contact with testosterone by touching areas where menhave used Vogelxo. Children and women should avoid contact with theunwashed or not covered (unclothed areas) where Vogelxo has been applied toyour skin. Vogelxo can transfer from your body to othersincluding, children and women. The study demonstrated that the overall effect of washing wasto decrease testosterone concentrations; however, when washing occurred two ormore hours post drug application, serum testosterone concentrations remainedwithin the normal range. In a clinical study conducted to evaluate the effect ofhand washing on the residual amount of testosterone, 36 healthy male subjectsreceived 50 mg of testosterone from 5 g of Vogelxo on a hand and appliedtestosterone gel to the upper arm and shoulder of one side. The potential for dermal testosterone transfer following Vogelxo use was evaluated in a clinical study betweenmales dosed with Vogelxo and their untreated female partners. It is unclear if the use of testosterone for low levels due to aging is beneficial or harmful. By staying informed and proactive, American men can navigate the complexities of testosterone therapy with confidence and care. American men using Androgel must be proactive in managing their health, particularly in relation to liver function. If liver function tests indicate issues, adjustments to the treatment plan, such as dosage changes or alternative therapies, may be necessary. They should educate patients about the potential risks and the importance of regular monitoring. Never give yourVogelxo to anyone else, even if they have the same symptoms you have. Vogelxo is a controlled substance (CIII) because itcontains testosterone that can be a target for people who abuse prescriptionmedicines. Vogelxo is used to treat adult males who have low or notestosterone due to certain medical conditions. The active pharmacological ingredient in Vogelxo is testosterone. Each metered-dose pump container is capable of dispensing 60 pump actuations. Four pump actuations or eight pump actuations contain 50 mg or 100 mg of testosterone, respectively. One 5-g or two 5-g tubes/packets of Vogelxo contains 50 mg or 100 mg of testosterone, respectively.
